Stephen Clarke has 25 years experience in the development, funding, and commercialization of engineering and technologies based on applied science. Stephen s primary roles are leadership, strategy development, technology coach. Steven combines a passion for science, engineering and technology with a keen acumen for what's important to getting the problem solved.

From 1976 to 1985, Stephen worked in the design, engineering, and advanced manufacturing of aerospace gas turbines at Rolls Royce. During that time, he earned a BSc in mechanical engineering and an MSc in engineering enterprise management. In 1985, Stephen led a joint British Telecom and Aston University team that developed and implemented one of the world s first graphical user interfaces for enterprise management software systems. For this work, he was awarded a PhD in computer simulation and business policy design. Stephen then went on to spend several years working as a management consultant, first with BDO Binder Hamlyn (from 1987 to 1989) and then with Gemini Consulting (until 1992). During this time, he sold and managed assignments in business strategy, crisis management, M&A, corporate re-engineering, and supply-chain management..

Stephen cofounded his first company in 1992, and he continues to drive projects and help businesses solve technical challenges.

As director of AIC Technica's biotechnology program, Martin is responsible for guiding clients in the biotechnology industry, using his experience in medical devices, biosensors, chemical/biochemical transformations, and microfluidics.

Skilled in bringing products from concept to market, Martin has built thriving sales channels for key applications in medical devices, biosensors, ADME/Tox, biofuels synthesis, nanoparticle crystallization, electrochemistry, and GMP API (Good Manufacturing Practices for Active Pharmaceutical Ingredients).

His work using microfluidics and microliter/nanoliter samples led to both industrial and academic collaborations now fully supported by his AIC consultancy colleagues and AIC’s quality engineering.

Martin began his career as a medicinal chemist at GlaxoSmithKline, working on the synthesis and characterization of drug molecules, followed by post-graduate and post-doctoral studies in electrochemistry at Southampton University, UK. He later joined Abbott Diagnostics Division as a Senior Electrochemist, specializing in the technical support, product development, and testing of glucose sensors. Through detailed failure analysis, he was able to identify the issue responsible for a FDA recall and develop lateral solutions.

His fundamental research identified alternative reference electrodes and efficient redox mediators. His role developed into business critical project management, and he was instrumental in overcoming a decade’s long compliance issue. Martin later joined HEL to further develop his project management skills in designing and building laboratory automation equipment for the nuclear, chemical, pharmaceuticals, and biotech industries. Martin’s interests developed into continuous processing, and so he joined Syrris to develop markets and application space using continuous flow microfluidics. He helped expand the company's focus on chemical synthesis to biological screening, fuels, and materials science.

Martin earned a first-class honors degree in chemistry and a PhD in electrochemistry from the University of Southampton, UK.